demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 prophylaxis (excluding children)
Nuvaxovid (NVX-CoV2373) Novavax Novavax phase 2 South Africa ... Novavax phase 3 UK ... Keech Novavax PREVEND-19 phase 3 US ...

0 studies excluded by filtering options 1